Literature DB >> 6066894

Mode of action of I.C.I. 46,474 in preventing implantation in rats.

M J Harper, A L Walpole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6066894     DOI： 10.1677/joe.0.0370083

Source DB:  PubMed          Journal:  J Endocrinol        ISSN： 0022-0795            Impact factor:   4.286


× No keyword cloud information.
  15 in total

Review 1.  Physiological and molecular determinants of embryo implantation.

Authors:  Shuang Zhang; Haiyan Lin; Shuangbo Kong; Shumin Wang; Hongmei Wang; Haibin Wang; D Randall Armant
Journal:  Mol Aspects Med       Date:  2013-01-02

2.  The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

Review 3.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

Review 4.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Production of prostaglandins by the pseudopregnant rat uterus, in vitro, and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1alpha as a major product.

Authors:  L Fenwick; R L Jones; B Naylor; N L Poyser; N H Wilson
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

6.  Incorporation of [3H] uridine into the ribonucleic acid of rat uterus during pseudopregnancy and in the presence of I.C.I. 46474 [trans-1-(p-beta-dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene].

Authors:  J E O'Grady; P J Heald; A O'Hare
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

7.  New synthetic agent for the induction of ovulation: preliminary trials in women.

Authors:  A Klopper; M Hall
Journal:  Br Med J       Date:  1971-01-16

Review 8.  Tamoxifen: catalyst for the change to targeted therapy.

Authors:  V Craig Jordan
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

Review 9.  Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators.

Authors:  V Craig Jordan; Russell McDaniel; Fadeke Agboke; Philipp Y Maximov
Journal:  Steroids       Date:  2014-06-17       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.